Vaccination with FasL‐/TCL plus MHSP65 induces improved anti‐lung cancer immunity in mice
Sign Up to like & getrecommendations! Published in 2018 at "International Immunopharmacology"
DOI: 10.1016/j.intimp.2017.12.029
Abstract: ABSTRACT In a previous study, we constructed a MHSP65‐TCL anti‐lung cancer vaccine with Lewis lung carcinoma TCL plus MHSP65, and illustrated its anti‐lung cancer effect through specific and nonspecific anti‐tumor immunity. However, TCL contains some… read more here.
Keywords: tcl; fasl tcl; mhsp65 fasl; lung ... See more keywords